Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Estradiol Levels and Lung Cancer Outcomes
Author
Howard (Jack) West, MD

This work is still early, but it's been interesting to see a lab-based correlate emerge along with with the observation of women, and particularly older women, doing better in lung cancer studies (several prior posts here). Last year, the folks at Cell Therapeutics, Inc., analyzed results from their trials with Xyotax (post here), which demonstrated that their favorable results were seen in younger women. Estrogen may be very relevant to several biological processes related to lung cancer (reviewed in this post), so there is reason to believe that sex differences in lung cancer outcomes are plausible.

Results at ASCO this year were notable for a couple of presentations that noted a correlation of estradiol levels with lung cancer outcomes. Estradiol is the major form of estrogen in humans, the "female" hormone, although levels are present in men as well. The results for women under 60 vs. 60 and older in a couple of xyotax trials were broken down by estradiol levels. Women with lower estradiol levels did better regardless of their age, while those with higher estradiol levels did less well, again regardless of their age:

estradiol and age in women (Click to enlarge)

So age appears to be more of a surrogate for hormonal status than an independent prognostic factor, at least according to an early analysis.

It would be interesting, though, to see if estradiol levels were also prognostic in men, since men also have detectable levels. In fact, that was looked at in the Xyotax trials, and would you believe that the men with lower estradiol levels (below the median) had a significantly longer survival than the men with higher estradiol levels? Here's the figure for the results, among 318 of 583 men on the STELLAR-3 (carbo/taxol vs. carbo/xyotax) or STELLAR-4 trial (gemcitabine or navelbine vs. xyotax) who had serum samples available:

estradiol in men Note: Estradiol levels are measured differently than in the above curve in women, hence the different numbers (scale).

Unlike women on these xyotax trials, men didn't do better with xyotax regardless of their estradiol levels.

There are trials that are just now beginning to look into using anti-estrogen therapies like tamoxifen or faslodex (fulvestrant) in combination with tarceva or other anti-cancer strategies, to see whether they will confer the survival benefit that seems to be present for post-menopausal women to pre-menopausal women, or maybe even men. Right now, we haven't seen the results of these trials, but I'll be watching for more and will keep everyone posted if we learn more.

Next Previous link

Previous PostNext Post

Related Content

Article
Don't let the word "small" deceive you. Small cell lung cancer (SCLC) casts a long shadow, impacting lives with its aggressive nature and the complexities of its treatment. But while the challenges are real, so is the progress. Breakthroughs in small cell lung cancer treatment offer hope. Immunotherapy plus chemo-radiation improves survival by 22 months. Screening catches it early.
Image
Blood Cancer Video Library 2024
Video
In these videos,  Dr. Levavi discusses what blastic plasmacytoid dendritic cell neoplasm (BPDCN) is, why people get it, how frequent the disease is, who it affects and its epidemiology. Also, how patients are diagnosed, recent advances among other topics related to BPDCN.  To watch the complete playlist, click here.  

Forum Discussions

Can SCLC also be treated with targeted therapy?

Hi amitchouhan,

Welcome to Grace. At this time, there aren't any targeted therapies to treat SCLC, but there are new treatments. Check out our latest OncTalk webinar from December. The last...

I was searching for this, Thank you so much for the info.

Glad to help.  FYI, I just edited the link, which has the agenda and links to oncologists' bios. Plus, the link is also on our home page, https://cancergrace.org/

Hope to see...

Recent Comments

JOIN THE CONVERSATION
Thank you for sharing
By LeviDrake on
Hi bluesun,I don't know of…
By JanineT GRACE … on
Amivantamab and Lazertinib
By happybluesun on
Glad to help.  FYI, I just…
By JanineT GRACE … on